Labiotech.eu

Podcast 7 Feb 2025

Targeting the dark genome to develop new therapies to fight obesity

This week, our podcast guest is Samir Ounzain, CEO of Haya Therapeutics. Ounzain was one of the first researchers to publish on lncRNA, also known as the ‘dark genome.’

February 7, 2025

News and Trends 6 Feb 2025

Top biotech deals of January 2025

January 2025 kicked off in full swing with several biotech deals in the biopharma industry.

February 6, 2025 - 8 minutesmins - By Roohi Mariam Peter

In Depth 5 Feb 2025

Needle-free vaccines: Micron Biomedical, Vaxxas, and IntegriMedical bring their new technologies to patients

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in this space.

February 5, 2025 - 11 minutesmins - By Willow Shah-Neville

In Depth 4 Feb 2025

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer care in 2025.

February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter

News and Trends 4 Feb 2025

Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach

February 4, 2025 - 6 minutesmins - By Jules Adam

In Depth 3 Feb 2025

The biggest biotech funding rounds in January 2025

The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January 2025.

February 3, 2025 - 4 minutesmins - By Willow Shah-Neville

News and Trends 31 Jan 2025

U.K. biotech defies the odds, raising £3.5B in 2024

The U.K. biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

January 31, 2025 - 7 minutesmins - By Roohi Mariam Peter

Podcast 31 Jan 2025

Can tumor activated therapy kill solid tumors?

Solid tumors are a big challenge. However, a new approach might provide the answer – tumor-activated Therapy. We discuss this with Seekyo Therapeutics’ CEO, Oury Chetboun

January 31, 2025

Best in Biotech 30 Jan 2025

Seven genome sequencing companies to look out for

There are a number of genomics startups that have sprouted up to strengthen their sequencing technologies to aid in disease prevention and treatment.

January 30, 2025 - 9 minutesmins - By Roohi Mariam Peter

In Depth 29 Jan 2025

Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic

Discover the treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to treat.

January 29, 2025 - 8 minutesmins - By Willow Shah-Neville

News and Trends 28 Jan 2025

ITM-11 succeeds in phase 3: The first big win for radiopharma?

Discover ITM and its cancer candidate ITM-11, as it brings one of the first big wins the radiopharmaceutical sector awaits.

January 28, 2025 - 9 minutesmins - By Jules Adam

Best in Biotech 27 Jan 2025

Top 19 most-performing biotech stocks of 2024

Discover the top-performing biotech stocks in 2024 – from oncology to psychedelics some companies showed remarkable results.

January 27, 2025 - 8 minutesmins - By Jules Adam

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Targeting the dark genome to develop new therapies to fight obesity

Top biotech deals of January 2025

Needle-free vaccines: Micron Biomedical, Vaxxas, and IntegriMedical bring their new technologies to patients

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology

The biggest biotech funding rounds in January 2025

U.K. biotech defies the odds, raising £3.5B in 2024

Can tumor activated therapy kill solid tumors?

Seven genome sequencing companies to look out for

Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic

ITM-11 succeeds in phase 3: The first big win for radiopharma?

Top 19 most-performing biotech stocks of 2024

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!